Y-Mabs Therapeutics Overview

Y-Mabs Therapeutics Cost of Revenue

Cost of Revenue analysis for YMAB.

Quarterly Cost of Revenue

$2.66M

↓ 11.68% YoY

As of Jun 30, 2025

Annual Cost of Revenue (TTM)

$13.51M

↑ 37.18% YoY

Trailing 12 months ending Jun 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin